Background: Memory CD4 T cells expressing the integrin α4β7 seem highly susceptible to HIV-1 infection, and may represent a preferential site for viral infection and reservoir establishment. Recent studies suggested that when used in combination with regular antiretroviral therapy during acute SIV infection, monoclonal antibodies blocking α4β7 may enable rhesus macaques to control viremia after ART discontinuation. In contrast, a clinical trial with α4β7 blocking antibodies in humans with chronic HIV-1 infection has recently been completed, without markedly increased frequencies of individuals achieving post-treatment control. Methods: PBMCs were isolated from HIV-1 positive patients (n=4) during acute seroconversion before ART initiation ...
Objectives: HIV establishes a latent infection at different degrees within na\uefve (TN) or central ...
Background: Integrin α4β7 (α4β7) mediates the homing of CD4+ T cells to gut-associated lymphoid tiss...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
The source and dynamics of persistent HIV-1 during long-term combinational antiretroviral therapy (c...
Virologic suppression with antiretroviral therapy (ART) has significantly improved health outcomes f...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
Understanding the impact of antiretroviral therapy (ART) duration on HIV-infected cells is critical ...
Despite the efficacy of antiretroviral therapy (ART), HIV persists in a latent form and remains a hu...
Control of HIV replication is a rare immunological event, providing clues to understand the viral co...
This study provides further evidence that the latent reservoir is comprised of both CD4+ T cells and...
BACKGROUND: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
International audienceBACKGROUND: Therapeutic control of HIV replication reduces the size of the vir...
Several studies have identified main changes in T- and B-lymphocyte subsets during chronic HIV infec...
Eradication of HIV infection will require the identification of all cellular reservoirs that harbor ...
Background: HIV Controllers spontaneously control HIV replication to very low levels (< 50 copies HI...
Objectives: HIV establishes a latent infection at different degrees within na\uefve (TN) or central ...
Background: Integrin α4β7 (α4β7) mediates the homing of CD4+ T cells to gut-associated lymphoid tiss...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
The source and dynamics of persistent HIV-1 during long-term combinational antiretroviral therapy (c...
Virologic suppression with antiretroviral therapy (ART) has significantly improved health outcomes f...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
Understanding the impact of antiretroviral therapy (ART) duration on HIV-infected cells is critical ...
Despite the efficacy of antiretroviral therapy (ART), HIV persists in a latent form and remains a hu...
Control of HIV replication is a rare immunological event, providing clues to understand the viral co...
This study provides further evidence that the latent reservoir is comprised of both CD4+ T cells and...
BACKGROUND: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
International audienceBACKGROUND: Therapeutic control of HIV replication reduces the size of the vir...
Several studies have identified main changes in T- and B-lymphocyte subsets during chronic HIV infec...
Eradication of HIV infection will require the identification of all cellular reservoirs that harbor ...
Background: HIV Controllers spontaneously control HIV replication to very low levels (< 50 copies HI...
Objectives: HIV establishes a latent infection at different degrees within na\uefve (TN) or central ...
Background: Integrin α4β7 (α4β7) mediates the homing of CD4+ T cells to gut-associated lymphoid tiss...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...